SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.
Wang Z, Yang X, Mei X, Zhou Y, Tang Z, Li G, Zhong J, Yu M, Huang M, Su X, Lin B, Cao P, Yang J, Ran P.
Wang Z, et al. Among authors: huang m.
Signal Transduct Target Ther. 2022 Apr 23;7(1):132. doi: 10.1038/s41392-022-00978-0.
Signal Transduct Target Ther. 2022.
PMID: 35461307
Free PMC article.